Skip to content

Assessment of drug related problems in Caner Patients By Pharmacist with iMAP tool by Pharmacist

Pharmacists evaluation of Medication Related Problems with Cancer:An Individualized Medication Assessment and Planning (iMAP)approach - A Randomized Controlled Study

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/09/036184
Enrollment
238
Registered
2021-09-02
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C00-D49- Neoplasms

Interventions

Intervention1: Pharmacist led Intervention on Medication Related Problems of Adults with Cancer through An Individualized Medication Assessment and Planning (iMAP): Patient counseling to detect, under

Sponsors

KLE Academy of Higher Education and Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Cancer patients who are undergone chemotherapy ( above 18 years). 2. Admitted inpatient Department.

Exclusion criteria

Exclusion criteria: 1. Those Older cancer patients are not willing to participate.

Design outcomes

Primary

MeasureTime frame
â?¢ Ensures optimum therapeutic outcomes for targeted beneficiaries through improved medication use â?¢ Reduces the risk of adverse events â?¢ Is developed in cooperation with licensed and practicing pharmacists and physicians â?¢ Describes the resources and time required to implement the program if using outside personnel and establishes the fees for pharmacists.Timepoint: 8th week of the study

Secondary

MeasureTime frame
1. To check the compliance of chemotherapy and quality of life of cancer patientsTimepoint: 8th week of the study

Countries

India

Contacts

Public ContactM S GANACHARI

KLE College of Pharmacy Belagavi

msganachari@gmail.com9448634457

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026